Yahoo Web Search

Search results

    • Analyst Report: Gilead Sciences, Inc.

      Morningstar Research via Yahoo Finance· 1 hour ago

      Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions ...